共 180 条
[1]
Bowtell DD(2015)Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Nat Rev Cancer 15 668-679
[2]
Böhm S(2017)The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway Cell Death Differ 24 1488-1501
[3]
Ahmed AA(2013)CuratedOvarianData: clinically annotated data for the ovarian cancer transcriptome Database (Oxford) 2013 bat013-2965
[4]
Aspuria PJ(2012)Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients PLoS One 7 e31885-1772
[5]
Bast RC(2018)Transition of mesenchymal and epithelial cancer cells depends on α1–4 galactosyltransferase-mediated glycosphingolipids Cancer Res 78 2952-2350
[6]
Beral V(2016)The roles of the Hippo pathway in cancer metastasis Cell Signal 28 1761-3866
[7]
Berek JS(2005)Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia Leukemia 19 2347-166
[8]
Birrer MJ(2008)Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73 Blood 112 3856-2436
[9]
Blagden S(2017)MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells Gynecol Oncol 145 159-6443
[10]
Bookman MA(2008)TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway Mol Cell Biol 28 2426-5716